10.7:license agreement dated as of october 12, 2005, between the registrant and uluru, inc. (incorporated by reference to exhibit 10.26 of our 10-k for the year ended december 31, 2005)
10.12:license agreement, dated june 6, 2013, by and between us and amag pharmaceuticals, inc. (incorporated by reference to exhibit 10.6 to our form 10-q for the quarter ended june 30, 2013)
10.13:license agreement, dated september 19, 2014, by and between us and plasma technologies, llc. (incorporated by reference to exhibit 10.30 of our form 8-k filed september 24, 2014)
10.15:amendment no. 1 to license agreement, dated september 19, 2014, by and between us and plasma technologies, llc, dated january 23, 2015 (incorporated by reference to exhibit 10.29 to our form 10-k for the year ended december 31, 2014)
